Latest news with #exocad™
Business Wire
6 days ago
- Business
- Business Wire
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of twelve research grants to universities under the company's fifteenth Annual Research Award Program. "Align is pleased to grant the following research awards that will lead to insights and evidence that advance the science and applicability of treatment for patients of all ages,' said Dr. Mitra Derakhshan, Align EVP, chief clinical officer. 'Align is pleased to grant the following research awards that will lead to insights and evidence that advance the science and applicability of treatment for patients of all ages,' said Dr. Mitra Derakhshan, Align executive vice president, chief clinical officer, global treatment planning and clinical services. 'We are excited to support university research around the world, and we continue to learn about the findings from the awarded research and their publications.' The Americas research award recipients for 2025 are: University of Alberta (Edmonton, Canada) Primary Investigator - Dr. Carlos Flores-Mir University of Florida (Gainesville, FL) Primary Investigator - Dr. Sarah Hisham Abu Arqub University of Rochester (Monroe County, NY) Primary Investigator - Dr. Dimitrios Michelogiannakis State University of Rio de Janeiro (Rio de Janeiro, Brazil) Primary Investigator - Dr. Jonas Capelli Junior The European research award recipients for 2025 are: University of Liège (Wallonia, Belgium) Primary Investigator - Dr. Baurin Basil Link Campus University (Rome, Italy) Primary Investigator - Dr. Giuseppina Laganà UniCamillus International Medical University (Rome, Italy) Primary Investigator - Dr. Roberta Lione Link Campus University (Rome, Italy) Primary Investigator - Dr. Giuseppina Laganà The Asia Pacific research award recipients for 2025 are: Sichuan University (Chengdu, China) Primary Investigator - Dr. Wenli Lai Sydney Dental Hospital (Surry Hills, Australia) Primary Investigator - Dr. Narayan H. Gandedkar Sichuan University (Chengdu, China) Primary Investigator - Dr. Yating Yi Sichuan University (Chengdu, China) Primary Investigator - Dr. Hu Long 'This year the number of applications to the program is the largest since its initiation fifteen years ago,' said John Morton, Align vice president, technical fellow. 'The research endeavors funded by this highly competitive program may advance the science of dentistry and aim to improve the dental care of the global community. We are proud to provide this opportunity to these excellent university researchers throughout the world.' The funded research studies cover a wide range of topics, including: Prediction of adolescent adherence to clear aligner treatment Effects of clinical consultation methods on the acceptance of the Invisalign treatment plan Evaluation of the precision of clear aligner composite attachment bonding immediately after bonding Evaluation of the behavior of biological markers of orthodontic movement in clear aligner treatment Impact of 3D imaging visualization tool during orthodontic treatment planning with aligners to reduce periodontal recession occurrence Comparison of lower incisors control during treatment with clear aligners versus fixed appliance and class II elastics Study of displaced maxillary canines with interceptive treatment by means of clear aligners Analysis of tri-dimensional upper and lower arch expansion comparing two protocols for mixed dentition Analysis of the predictability of molar intrusion and incisor extrusion with different treatment protocols among open-bite patients treated with Invisalign clear aligners Comparison of periodontal health outcomes between Invisalign clear aligners and fixed appliances Study orthodontic alveolar bone remodeling in vivo, and investigate possible ways to assess bone remodeling from a 3D perspective Evaluation of the clinical efficacy of clear aligners in rotating the occlusal plane and mandibular plane for functional esthetics among skeletal class II high-angle patients All award applications received were first reviewed and prioritized in a blind evaluation by an independent academic committee. The final recipients were then determined by Align Technology. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
Business Wire
22-05-2025
- Business
- Business Wire
Align Technology Launches Professional Marketing Initiative Featuring Doctors at the Forefront of Digital Orthodontics and Their Stories in Transforming More Than 20M Smiles With Invisalign ® Aligners
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new professional marketing initiative spanning across the EMEA region and North America to provide doctors with a platform to share their stories about transforming smiles and changing lives for their patients and practices. The initiative includes regional campaigns that celebrate doctors' achievements by showcasing a variety of real, emotional, and inspiring stories, each shining a light on the meaningful work that doctors do every day. 'The support, trust, and expertise of our doctor customers around the world are critical factors in all that we do,' said Joe Hogan, president and CEO, Align Technology. ' Share 'The support, trust, and expertise of our doctor customers around the world are critical factors in all that we do,' said Joe Hogan, president and CEO, Align Technology. 'They continuously inspire each of us in how they combine Align digital tools and technology with their knowledge and expertise to improve oral health and to transform smiles and change lives for their patients.' This initiative is an overarching, ongoing effort to recognize and celebrate doctors, their practices, and their patients. With an initial focus on orthodontists, these campaigns use compelling, relatable short form videos of authentic doctors' stories shared across multiple media platforms to highlight a unique journey, a challenge overcome, or a meaningful connection with patients. The first two iterations of the campaign are launching in the EMEA region and North America, with stories released throughout the year on dedicated landing pages: The 'We See Your Brilliance' campaign will be available digitally across EMEA starting on May 23 rd in 7 languages and at the European Aligner Society (EAS6) Congress 2025 in Rhodes. Link to campaign: 'The Innovators Behind the Smile' campaign will be available digitally in North America starting on May 22 nd. Link to campaign: 'A smile can truly transform a life—and behind every confident smile is the expertise, dedication, and brilliance of a doctor. Their work goes far beyond aligning teeth; it's about restoring confidence and changing lives. This campaign is a tribute to all doctors and their staff, whose passion and precision leave a lasting impact,' said Khilola Shukurova, Align vice president marketing, EMEA. 'Doctors across the world have transformed smiles and changed the lives of patients – from kids to teens to adults of all ages,' said Kamal Bhandal, Align senior vice president, Global Brand, Consumer and Americas Marketing. 'This campaign shines a light on the innovators behind the smiles - the doctors in local communities around the world. We look forward to sharing and celebrating their inspirational stories of connection with their patients and building confident new smiles.' About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
Yahoo
28-03-2025
- Business
- Yahoo
SprintRay Inc. Announces API Integration with Align Technology's iTero™ Intraoral Scanners to Further Ease Adoption into Chairside Digital Dentistry
LOS ANGELES, March 28, 2025 /PRNewswire/ -- SprintRay, a leader in dental 3D printing, announces a new application programming interface (API) integration with Align Technology's iTero™ intraoral scanners. The direct integration between iTero™ intraoral scanners and SprintRay's 3D printing ecosystem, including the new Midas Digital Press and advanced restorative materials enhances the feasibility of same-day restorations. Providers can directly import scan data to the SprintRay Cloud by selecting it on the iTero™ prescription form and sending the scan once completed. These steps give access to SprintRay's AI-powered design services and cutting-edge 3D printing technology to facilitate the production of crowns, veneers, and other dental applications. The Midas Digital Press, combined with next-generation restorative materials, further refines the workflow by delivering stronger, more esthetic, and highly durable printed restorations. This innovation allows dentists to embrace chairside technology with minimal effort, offering high-quality, patient-ready restorations in a single visit. The collaboration between Align Technology and SprintRay responds to the evolving needs of modern dentistry and patient preferences, providing an efficient alternative to traditional lab-based workflows. As chairside dentistry continues to gain traction, this integration underscores the evolution of digital dental workflows (in-office or lab-based), offering clinicians more clinical options, efficiency and management of patient care. The SprintRay and iTero scanners API integration is now available on all iTero scanner models in available markets. For more information about it, please visit Learn more about SprintRay printers or any of SprintRay innovative solutions at About SprintRaySprintRay is a dental technology company that builds end-to-end 3D printing ecosystems for dental professionals. SprintRay designs and manufactures user-friendly and cutting-edge dental solutions including 3D printers and post-processing ecosystems, 3D printing software featuring AI technology, and innovative 3D resins. Dental care providers can deliver best-in-class service by leveraging SprintRay's highly specialized, affordable technologies. For more information, visit Media contact: press@ About Align Technology, Technology designs and manufactures the Invisalign® System, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271.6 thousand doctor customers and is key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat approximately 19.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. View original content: SOURCE SprintRay Sign in to access your portfolio
Yahoo
25-02-2025
- Business
- Yahoo
Align Technology Announces $225 Million Open Market Repurchase
TEMPE, Ariz., February 25, 2025--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $225 million of Align's common stock through open market repurchases, which will complete Align's $1.0 billion stock repurchase program that was approved by Align's Board of Directors in January 2023, in its entirety. "Today's announcement of our intention to repurchase $225 million of our common stock through open market repurchases reflects the strength of our balance sheet and cash flow generation, as well as management's and the Board's continued confidence in our ability to capitalize on our large market opportunity while allowing us to provide value back to our shareholders," said John Morici, Align CFO and executive vice president, global finance. "We have made strategic investments in technology and scalability to enable a new phase of growth to transform the orthodontic industry and we remain confident in our ability to make the Invisalign® System the standard of care in orthodontics through our doctor-centered model." The open market repurchases of Align's common stock will be executed pursuant to a Rule 10b5-1 trading plan. The timing and number of shares repurchased will be based on an evaluation of market conditions and other factors, including stock price, trading volume, general business and market conditions, and capital availability. The repurchases are expected to be completed by the beginning of May 2025 and will be funded with Align's cash on hand. As of December 31, 2024, Align had approximately 73.8 million shares outstanding and $1,043.9 million in cash and cash equivalents. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271.6 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat approximately 19.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc. Forward-Looking Statements This news release contains forward-looking statements including statements regarding the expected completion date of the open market repurchases, the aggregate value and number of shares of common stock to be repurchased, Align's expectation that it will finance the repurchases with cash on hand, our confidence in our products and investments and their ability to scale growth, our ability to capitalize on market opportunities, that the repurchases will provide value to our shareholders, as well as other statements regarding the open market repurchases along with our confidence in our business model. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission ("SEC"), including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on February 28, 2024 and our latest Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, which was filed with the SEC on November 5, 2024. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason. View source version on Contacts Align Technology Madelyn Valente(909) 833-5839mvalente@ Zeno Group Sarah Karlson(828) Sign in to access your portfolio
